BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Qian J, Oppermann E, Tran A, Imlau U, Qian K, Vogl TJ. Transarterial administration of integrin inhibitor loaded nanoparticles combined with transarterial chemoembolization for treating hepatocellular carcinoma in a rat model. World J Gastroenterol 2016; 22(21): 5042-5049 [PMID: 27275096 DOI: 10.3748/wjg.v22.i21.5042] [Cited by in CrossRef: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Deng Z, Wang H, Liu J, Deng Y, Zhang N. Comprehensive understanding of anchorage-independent survival and its implication in cancer metastasis. Cell Death Dis 2021;12:629. [PMID: 34145217 DOI: 10.1038/s41419-021-03890-7] [Reference Citation Analysis]
2 Shi Y, Wang X, Zhu Q, Chen G. The Ribosomal Protein L28 Gene Induces Sorafenib Resistance in Hepatocellular Carcinoma. Front Oncol 2021;11:685694. [PMID: 34307151 DOI: 10.3389/fonc.2021.685694] [Reference Citation Analysis]
3 Yuan Y, Liu Q, Wu Z, Luo W. Mechanistic Insight on the Interaction between OPN and Integrin ανβ3 in Osteoarthritis. Biomed Res Int 2020;2020:2905634. [PMID: 33134374 DOI: 10.1155/2020/2905634] [Reference Citation Analysis]
4 Babu A, Amreddy N, Muralidharan R, Pathuri G, Gali H, Chen A, Zhao YD, Munshi A, Ramesh R. Chemodrug delivery using integrin-targeted PLGA-Chitosan nanoparticle for lung cancer therapy. Sci Rep 2017;7:14674. [PMID: 29116098 DOI: 10.1038/s41598-017-15012-5] [Cited by in Crossref: 50] [Cited by in F6Publishing: 36] [Article Influence: 10.0] [Reference Citation Analysis]